Skip to main content
logo
ReShape Lifesciences Inc. (RSLS)
Aug 15, 2025 - RSLS was delisted (reason: merged into HIND)
15.68
0.00 (0.00%)
Inactive · Last trade price on Aug 14, 2025

ReShape Lifesciences Revenue

ReShape Lifesciences had revenue of $1.24M in the quarter ending June 30, 2025, a decrease of -36.79%. This brings the company's revenue in the last twelve months to $6.45M, down -19.81% year-over-year. In the year 2024, ReShape Lifesciences had annual revenue of $8.01M, down -7.74%.

Revenue (ttm)
$6.45M
Revenue Growth
-19.81%
P/S Ratio
0.20
Revenue / Employee
$358,444
Employees
18
Market Cap
10.56M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.01M-672.00K-7.74%
Dec 31, 20238.68M-2.56M-22.79%
Dec 31, 202211.24M-2.36M-17.35%
Dec 31, 202113.60M2.30M20.36%
Dec 31, 202011.30M-3.79M-25.12%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

RSLS News

More News